Clinical Trials Directory

Explore 21,535 clinical trials worldwide

Showing 12901-12950 of 21,535 trials

Active filters:Status: Active, not recruiting

Clinical Trials (21,535)

NCT04801381
WATER III: Aquablation vs. Transurethral Laser Enucleation of Large Prostates (80 - 180mL) in Benign Prostatic Hyperplasia
NAActive, not recruiting
202 participants
Started: Dec 16, 2020 · Completed: Oct 31, 2029
1 condition2 sponsors5 locations
NCT04375332
Beating Heart Mitral Valve Repair With the HARPOON™ System
NAActive, not recruiting
25 participants
Started: Dec 16, 2020 · Completed: Dec 20, 2027
1 condition1 sponsor9 locations
NCT04437043
A Multicenter Belgian Trial of Ventral Hernia Repair (UNITE)
NAActive, not recruiting
100 participants
Started: Dec 16, 2020 · Completed: Dec 30, 2024
1 condition3 sponsors1 location
NCT04064762
Targeted Plasticity Therapy for Posttraumatic Stress Disorder
NAActive, not recruiting
9 participants
Started: Dec 16, 2020 · Completed: Apr 30, 2024
1 condition4 sponsors1 location
NCT04443348
Pre-op Pembro + Radiation Therapy in Breast Cancer (P-RAD)
PHASE2Active, not recruiting
120 participants
Started: Dec 16, 2020 · Completed: Aug 31, 2027
3 conditions4 sponsors10 locations
NCT04626479
Substudy 03A: A Study of Immune and Targeted Combination Therapies in Participants With First Line (1L) Renal Cell Carcinoma (MK-3475-03A)
PHASE1/PHASE2Active, not recruiting
400 participants
Started: Dec 16, 2020 · Completed: May 31, 2026
1 condition1 sponsor55 locations
NCT04192747
The Elixir Bioadaptor vs. The Onyx Stent in De Novo Native Coronary Arteries
NAActive, not recruiting
445 participants
Started: Dec 16, 2020 · Completed: Feb 28, 2027
4 conditions1 sponsor36 locations
NCT04655248
ACURATE neo2™ Post Market Clinical Follow up Study
N/AActive, not recruiting
250 participants
Started: Dec 16, 2020 · Completed: Dec 31, 2026
3 conditions1 sponsor19 locations
NCT04661007
To Assess the Safety and Tolerability of Tafasitamab Alone or in Combination With Other Drugs in Japanese Participants With Non-Hodgkins Lymphoma (NHL)
PHASE1/PHASE2Active, not recruiting
72 participants
Started: Dec 15, 2020 · Completed: Dec 31, 2026
2 conditions1 sponsor23 locations
NCT04582695
Early Intervention Following Sexual Assault
NAActive, not recruiting
60 participants
Started: Dec 15, 2020 · Completed: Jan 31, 2026
3 conditions2 sponsors1 location
NCT04700969
Onset PrevenTIon of Urinary Retention in Orthopaedic Nursing and Rehabilitation
NAActive, not recruiting
20 participants
Started: Dec 15, 2020 · Completed: May 30, 2027
3 conditions3 sponsors17 locations
NCT05161325
A Study of Effectiveness and Safety of the First-Line Nivolumab Plus Ipilimumab With or Without Chemotherapy for Advanced/Recurrent Non-Small Cell Lung Cancer in Japan
N/AActive, not recruiting
525 participants
Started: Dec 15, 2020 · Completed: Jun 1, 2026
1 condition2 sponsors1 location
NCT04619797
A Study of Tiragolumab in Combination With Atezolizumab Plus Pemetrexed and Carboplatin/Cisplatin Versus Pembrolizumab Plus Pemetrexed and Carboplatin/Cisplatin in Participants With Previously Untreated Advanced Non-Squamous Non-Small Cell Lung Cancer
PHASE2/PHASE3Active, not recruiting
542 participants
Started: Dec 15, 2020 · Completed: Sep 30, 2025
1 condition1 sponsor128 locations
NCT04561232
Locomotor Learning in Infants at High Risk for Cerebral Palsy
NAActive, not recruiting
60 participants
Started: Dec 15, 2020 · Completed: Mar 1, 2026
1 condition4 sponsors1 location
NCT04624633
Acalabrutinib, Umbralisib, and Ublituximab (AU2) In Relapsed and Untreated CLL
PHASE2Active, not recruiting
29 participants
Started: Dec 15, 2020 · Completed: Jan 1, 2028
4 conditions3 sponsors1 location
NCT04950842
Induction of Transplant Tolerance in LDLT Via iTS
PHASE1/PHASE2Active, not recruiting
10 participants
Started: Dec 15, 2020 · Completed: Feb 28, 2026
1 condition2 sponsors5 locations
NCT04670679
A Dose Escalation/Expansion Study of ERAS-601 in Patients With Advanced or Metastatic Solid Tumors
PHASE1Active, not recruiting
200 participants
Started: Dec 15, 2020 · Completed: Feb 28, 2026
1 condition1 sponsor14 locations
NCT04245423
The Whole Health Study: Collaborative Care for OUD and Mental Health Conditions
NAActive, not recruiting
567 participants
Started: Dec 15, 2020 · Completed: Feb 28, 2026
2 conditions2 sponsors1 location
NCT04787341
PAnitumumab REchallenge Followed by REgorafenib Versus the Reverse Sequence
PHASE2Active, not recruiting
214 participants
Started: Dec 15, 2020 · Completed: Dec 15, 2025
1 condition3 sponsors1 location
NCT04586426
A Study of the Combination of Talquetamab and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
PHASE1/PHASE2Active, not recruiting
228 participants
Started: Dec 15, 2020 · Completed: Oct 27, 2026
1 condition1 sponsor40 locations
NCT04907201
H-reflex in Spastic Lower Limb Cryoneurotomy
N/AActive, not recruiting
60 participants
Started: Dec 15, 2020 · Completed: Nov 30, 2024
1 condition1 sponsor1 location
NCT04610515
Innovative Support for Patients With SARS-COV2 Infections (COVID-19) Registry (INSPIRE)
N/AActive, not recruiting
6,000 participants
Started: Dec 15, 2020 · Completed: Dec 31, 2025
6 conditions8 sponsors8 locations
NCT04481048
Antioxidant Therapy With N-acetylcysteine for Children With Neurofibromatosis Type 1
PHASE2Active, not recruiting
58 participants
Started: Dec 15, 2020 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT04261569
Clinical Trial for Near Infrared Endoventricular Illumination for Neuroprotection in Very Early Cases of Parkinson's Disease (Ev-NIRT)
NAActive, not recruiting
14 participants
Started: Dec 14, 2020 · Completed: Apr 30, 2032
1 condition2 sponsors1 location
NCT04562766
Study to Evaluate Rilzabrutinib in Adults and Adolescents With Persistent or Chronic Immune Thrombocytopenia (ITP)
PHASE3Active, not recruiting
232 participants
Started: Dec 14, 2020 · Completed: Aug 26, 2026
1 condition1 sponsor155 locations
NCT04468672
Eating Behaviors in Shift Workers
NAActive, not recruiting
100 participants
Started: Dec 14, 2020 · Completed: Jun 30, 2026
2 conditions1 sponsor1 location
NCT04618913
Anticoagulation in Patients With Venous Thromboembolism and Cancer
N/AActive, not recruiting
1 participants
Started: Dec 14, 2020 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT04554121
Efficacy of Personalizing Cognitive Remediation for Schizophrenia by Targeting Impairments in Early Auditory Processing
NAActive, not recruiting
194 participants
Started: Dec 14, 2020 · Completed: Dec 31, 2025
2 conditions2 sponsors9 locations
NCT06909968
Identification of Palliative Care Needs and Prognostic Factors of Survival in Tailoring Appropriate Interventions in Advanced Oncological, Renal and Pulmonary Diseases
N/AActive, not recruiting
200 participants
Started: Dec 14, 2020 · Completed: Sep 30, 2025
4 conditions1 sponsor5 locations
NCT04522570
Thermal Ablation of Cervical Metastases From Thyroid Carcinoma
NAActive, not recruiting
84 participants
Started: Dec 14, 2020 · Completed: Nov 30, 2026
4 conditions1 sponsor1 location
NCT04599088
Investigation of Brain Mechanisms Involved in the Urinary Continence Mechanism Associated With Aging
NAActive, not recruiting
207 participants
Started: Dec 14, 2020 · Completed: Jan 3, 2026
1 condition2 sponsors1 location
NCT04681183
Pilot Study Evaluating Neuro-Imaging Correlates of Epigenetic Finding in Prediction of Chronic Postsurgical Pain
N/AActive, not recruiting
13 participants
Started: Dec 14, 2020 · Completed: Dec 1, 2024
1 condition1 sponsor1 location
NCT04673266
Using Romiplostim to Treat Low Platelet Counts During Chemotherapy in People With Lymphoma
PHASE2Active, not recruiting
11 participants
Started: Dec 14, 2020 · Completed: Dec 31, 2026
2 conditions3 sponsors8 locations
NCT03894059
An Educational Program to Improve Cardiac Arrest Diagnostic Accuracy of Ambulance Telecommunicators
N/AActive, not recruiting
12,224 participants
Started: Dec 14, 2020 · Completed: Dec 31, 2025
6 conditions8 sponsors1 location
NCT04645212
Long-term Study of ADVM-022 in Neovascular (Wet) AMD [OPTIC-EXT]
N/AActive, not recruiting
23 participants
Started: Dec 14, 2020 · Completed: Jun 30, 2025
2 conditions1 sponsor9 locations
NCT04685343
Behavioral and Neural Phenotypes of Primary Dysmenorrhea in Adolescents
NAActive, not recruiting
164 participants
Started: Dec 14, 2020 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT04652076
GYNecological Cancers Treated with NETrin MAbs in Combination with Chemotherapy and /or Pembrolizumab
PHASE1/PHASE2Active, not recruiting
240 participants
Started: Dec 14, 2020 · Completed: Jul 30, 2026
2 conditions3 sponsors15 locations
NCT04987099
Effects of Increased Maternal Choline Intake on Child Cognitive Development
NAActive, not recruiting
40 participants
Started: Dec 13, 2020 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT04843501
Middle School Cluster Randomized Controlled Trial (RCT) to Evaluate E-Cigarette Prevention Program: CATCH My Breath
NAActive, not recruiting
1,790 participants
Started: Dec 13, 2020 · Completed: Dec 1, 2024
1 condition2 sponsors1 location
NCT04338399
The BURAN Study of Buparlisib in Patients With Recurrent or Metastatic HNSCC
PHASE3Active, not recruiting
483 participants
Started: Dec 12, 2020 · Completed: Jun 30, 2026
1 condition1 sponsor162 locations
NCT04452955
A Study to Assess Safety and Efficacy of PRL3-Zumab in Patients with Solid Tumors
PHASE2Active, not recruiting
51 participants
Started: Dec 12, 2020 · Completed: Dec 1, 2025
1 condition2 sponsors5 locations
NCT05673902
Study of the Safety and Efficacy of RPH-104 in Preventing Recurrences in Patients With Idiopathic Recurrent Pericarditis
PHASE3Active, not recruiting
17 participants
Started: Dec 11, 2020 · Completed: Jan 31, 2026
1 condition5 sponsors1 location
NCT04573478
Atrasentan in Patients With IgA Nephropathy
PHASE3Active, not recruiting
404 participants
Started: Dec 11, 2020 · Completed: Dec 18, 2026
2 conditions1 sponsor135 locations
NCT04635995
Phase 1 Trial of LVGN7409 (CD40 Agonist Antibody) as Single Agent and Combination Therapies in Advanced or Metastatic Malignancy
PHASE1Active, not recruiting
126 participants
Started: Dec 11, 2020 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT04333823
Adolescent Type 1 Diabetes Treatment With SGLT2i for hyperglycEMia & hyPerfilTration Trial
PHASE3Active, not recruiting
100 participants
Started: Dec 11, 2020 · Completed: May 31, 2024
1 condition3 sponsors3 locations
NCT04198922
Acalabrutinib for the Treatment of Chronic Graft Versus Host Disease
PHASE2Active, not recruiting
51 participants
Started: Dec 11, 2020 · Completed: Apr 30, 2027
2 conditions2 sponsors6 locations
NCT04604314
Alternative EndoCrowns Designs for Chairside CAD/CAM
NAActive, not recruiting
69 participants
Started: Dec 10, 2020 · Completed: Dec 1, 2027
1 condition2 sponsors1 location
NCT04684940
Safety, Tolerability, and Efficacy Study of Valoctocogene Roxaparvovec in Hemophilia A With Active or Prior Inhibitors
PHASE1/PHASE2Active, not recruiting
10 participants
Started: Dec 10, 2020 · Completed: Apr 30, 2029
2 conditions1 sponsor9 locations
NCT04543591
Ravulizumab in Thrombotic Microangiopathy After Hematopoietic Stem Cell Transplant
PHASE3Active, not recruiting
148 participants
Started: Dec 10, 2020 · Completed: Mar 20, 2026
1 condition1 sponsor67 locations
NCT04654260
Behavior Therapy for Irritability in Autism
NAActive, not recruiting
65 participants
Started: Dec 10, 2020 · Completed: Feb 28, 2026
7 conditions2 sponsors1 location